ARCHIVES

NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level

This article is from The Cancer Letter archive.

Vol. 40 No. 10 | March 7, 2014

Download PDF Visit The Full Archive

Related Articles

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000

NCI Proposes New Grants and Centers For Molecular Target-Based Therapeutics

March 26, 1999

Oral Therapy Sorafenib Improves Survival Of Advanced Liver Cancer In Study

June 29, 2007

High-Dose Chemo Doesn’t Improve Survival In Small Cell Lung Cancer

April 25, 2008

Grants Awarded To Combat Tobacco In Developing Countries

October 4, 2002

In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges

October 3, 1980